Results 1 to 10 of about 846,916 (323)

A novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cells. [PDF]

open access: yes, 2016
The MST1R gene is overexpressed in pancreatic cancer producing elevated levels of the RON tyrosine kinase receptor protein. While mutations in MST1R are rare, alternative splice variants have been previously reported in epithelial cancers.
Babicky, M   +10 more
core   +24 more sources

Correction to: Elf3 drives β-catenin transactivation and associates with poor prognosis in colorectal cancer [PDF]

open access: yesCell Death and Disease
J.-L. Wang   +10 more
doaj   +2 more sources

Characterisation of a cyclic peptide that binds to the RAS binding domain of phosphoinositide 3-kinase p110α

open access: yesScientific Reports, 2023
P110α is a member of the phosphoinositide 3-kinase (PI3K) enzyme family that functions downstream of RAS. RAS proteins contribute to the activation of p110α by interacting directly with its RAS binding domain (RBD), resulting in the promotion of many ...
Mohamed Ismail   +17 more
doaj   +1 more source

In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells [PDF]

open access: yes, 2015
Oncogenic signaling in melanocytes results in oncogene-induced senescence (OIS), a stable cell-cycle arrest frequently characterized by a bi- or multinuclear phenotype that is considered as a barrier to cancer progression.
Bröcker, E.-B.   +12 more
core   +6 more sources

β-catenin-promoted cholesterol metabolism protects against cellular senescence in naked mole-rat cells

open access: yesCommunications Biology, 2021
Woei-Yaw Chee et al. explore the molecular mechanisms of β-catenin involvement in cholesterol metabolism suppressing cellular senescence in naked mole-rat cells.
Woei-Yaw Chee   +9 more
doaj   +1 more source

Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry

open access: yesNature Communications, 2021
The tumour microenvironment (TME) may change in response to cancer treatments such as KRAS G12C inhibition, with potential implications for combination therapies. Here, the authors provide an antibody panel and workflow for analysing the TME with imaging
Febe van Maldegem   +17 more
doaj   +1 more source

Combined targeting of G protein‐coupled receptor and EGF receptor signaling overcomes resistance to PI3K pathway inhibitors in PTEN‐null triple negative breast cancer

open access: yesEMBO Molecular Medicine, 2020
Triple‐negative breast cancer (TNBC) has poorer prognosis compared to other types of breast cancers due to the lack of effective therapies and markers for patient stratification.
Davide Zecchin   +6 more
doaj   +1 more source

Exploiting RIG-I-like receptor pathway for cancer immunotherapy

open access: yesJournal of Hematology & Oncology, 2023
RIG-I-like receptors (RLRs) are intracellular pattern recognition receptors that detect viral or bacterial infection and induce host innate immune responses.
Yangfu Jiang   +6 more
doaj   +1 more source

RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma

open access: yesNature Communications, 2022
Mutations in RAS oncogenes and related pathways are frequent in lung cancers. Here, the authors derive a RAS gene expression signature and a machine learning classifier to predict drug response and clinical outcomes in lung adenocarcinoma and other solid
Philip East   +10 more
doaj   +1 more source

Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data

open access: yesCancer Biology & Medicine, 2022
This review will describe the global patterns and trends of colorectal cancer survival, using data from the population-based studies or cancer registration. We performed a systematic search of China National Knowledge Infrastructure (CNKI), Wanfang Data,
Yufei Jiang   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy